Global Desmopressin Acetate Market

Desmopressin Acetate Comprehensive Study by Type (Diabetes Insipidus, Nighttime Bedwetting), Route of Administration (Oral, Intravenous (IV)), Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospitals Pharmacies) Players and Region - Global Market Outlook to 2028

Desmopressin Acetate Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Desmopressin Acetate
Desmopressin is a drug that is used to reduce the amount of urine produced and the frequency with which it is produced. In children, desmopressin acetate is effective in avoiding overnight bedwetting. Desmopressin acetate is prescribed for patients whose bodies do not produce enough vasopressin, the hormone that regulates urine output. Reduced vasopressin production can be caused by a variety of circumstances, including brain surgery or a head injury. Desmopressin operates in a variety of ways, including limiting thirst, frequency of urination, amount of urine produced, and so on. Patients with diabetes insipidus, often known as water diabetes, may benefit from the drug. The market for desmopressin acetate is predicted to expand due to the rising prevalence of diabetes insipidus around the world. The market is projected to develop further as people become more aware of desmopressin acetate's availability. Manufacturers of desmopressin acetate are projected to expand their regional product footprint, as well as engage in various promotional efforts such as public awareness campaigns on how to prevent nocturnal bedwetting, diabetes insipidus treatment, and so on.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


Desmopressin Acetate is highly competitive, with several key players dominating the industry. The market players are focused on developing a variety of features and benefits to meet the needs and preferences of consumers. Thus, constantly introducing new innovation in processing to meet the changing needs and preferences of consumers. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Desmopressin Acetate market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Ferring Pharmaceuticals Inc. (United States), American Regent Inc.(United States), Sun Pharmaceutical Industries Ltd(India), Teva Pharmaceutical Industries Ltd. (Israel), Glenmark Pharmaceuticals(India), Mylan N.V.(United States), Pfizer(United States), Dr. Reddy's Laboratories (India), BluePoint Laboratories (Ireland) and Sanofi (France) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Desmopressin Acetate market by Type (Diabetes Insipidus and Nighttime Bedwetting) and Region.



On the basis of geography, the market of Desmopressin Acetate has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Route of Administration, the sub-segment i.e. Oral will boost the Desmopressin Acetate market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Retail Pharmacies will boost the Desmopressin Acetate market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Efforts to increase awareness by various childcare non-profit organizations

Market Growth Drivers:
The Rising Prevalence of Diabetes and Increase in Bedwetting Episodes in Children

Challenges:
Side Effects Related to Drug

Restraints:
Stringent Regulatory Factors

Opportunities:
Increasing Investment in Healthcare and Growing Research and Development Activities

May 2020 – Dr. Reddy's Laboratories announced the launch of Desmopressin Acetate Injection USP, 4 mcg/mL Single-dose Ampules, a therapeutic equivalent generic version of DDAVP (desmopressin acetate) Injection, 4 mcg/mL, approved by the U. S.Food and Drug Administration (USFDA).


Key Target Audience
Manufacturers of Desmopressin Acetate, Suppliers of Desmopressin Acetate, Pharmaceutical Companies, Hospitals and Regulatory Bodies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Diabetes Insipidus
  • Nighttime Bedwetting
By Route of Administration
  • Oral
  • Intravenous (IV)

By Distribution Channel
  • Retail Pharmacies
  • Online Pharmacies
  • Hospitals Pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rising Prevalence of Diabetes
      • 3.2.2. Increase in Bedwetting Episodes in Children
    • 3.3. Market Challenges
      • 3.3.1. Side Effects Related to Drug
    • 3.4. Market Trends
      • 3.4.1. Efforts to increase awareness by various childcare non-profit organizations
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Desmopressin Acetate, by Type, Route of Administration, Distribution Channel and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Desmopressin Acetate (Value)
      • 5.2.1. Global Desmopressin Acetate by: Type (Value)
        • 5.2.1.1. Diabetes Insipidus
        • 5.2.1.2. Nighttime Bedwetting
      • 5.2.2. Global Desmopressin Acetate by: Route of Administration (Value)
        • 5.2.2.1. Oral
        • 5.2.2.2. Intravenous (IV)
      • 5.2.3. Global Desmopressin Acetate by: Distribution Channel (Value)
        • 5.2.3.1. Retail Pharmacies
        • 5.2.3.2. Online Pharmacies
        • 5.2.3.3. Hospitals Pharmacies
      • 5.2.4. Global Desmopressin Acetate Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Desmopressin Acetate: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Ferring Pharmaceuticals Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. American Regent Inc.(United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sun Pharmaceutical Industries Ltd(India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Glenmark Pharmaceuticals(India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mylan N.V.(United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pfizer(United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Dr. Reddy's Laboratories (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BluePoint Laboratories (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sanofi (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Desmopressin Acetate Sale, by Type, Route of Administration, Distribution Channel and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Desmopressin Acetate (Value)
      • 7.2.1. Global Desmopressin Acetate by: Type (Value)
        • 7.2.1.1. Diabetes Insipidus
        • 7.2.1.2. Nighttime Bedwetting
      • 7.2.2. Global Desmopressin Acetate by: Route of Administration (Value)
        • 7.2.2.1. Oral
        • 7.2.2.2. Intravenous (IV)
      • 7.2.3. Global Desmopressin Acetate by: Distribution Channel (Value)
        • 7.2.3.1. Retail Pharmacies
        • 7.2.3.2. Online Pharmacies
        • 7.2.3.3. Hospitals Pharmacies
      • 7.2.4. Global Desmopressin Acetate Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Desmopressin Acetate: by Type(USD Million)
  • Table 2. Desmopressin Acetate Diabetes Insipidus , by Region USD Million (2017-2022)
  • Table 3. Desmopressin Acetate Nighttime Bedwetting , by Region USD Million (2017-2022)
  • Table 4. Desmopressin Acetate: by Route of Administration(USD Million)
  • Table 5. Desmopressin Acetate Oral , by Region USD Million (2017-2022)
  • Table 6. Desmopressin Acetate Intravenous (IV) , by Region USD Million (2017-2022)
  • Table 7. Desmopressin Acetate: by Distribution Channel(USD Million)
  • Table 8. Desmopressin Acetate Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 9. Desmopressin Acetate Online Pharmacies , by Region USD Million (2017-2022)
  • Table 10. Desmopressin Acetate Hospitals Pharmacies , by Region USD Million (2017-2022)
  • Table 11. South America Desmopressin Acetate, by Country USD Million (2017-2022)
  • Table 12. South America Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 13. South America Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 14. South America Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 15. Brazil Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 16. Brazil Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 17. Brazil Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 18. Argentina Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 19. Argentina Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 20. Argentina Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 21. Rest of South America Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 22. Rest of South America Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 23. Rest of South America Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 24. Asia Pacific Desmopressin Acetate, by Country USD Million (2017-2022)
  • Table 25. Asia Pacific Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 26. Asia Pacific Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 27. Asia Pacific Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 28. China Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 29. China Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 30. China Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 31. Japan Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 32. Japan Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 33. Japan Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 34. India Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 35. India Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 36. India Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 37. South Korea Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 38. South Korea Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 39. South Korea Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 40. Taiwan Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 41. Taiwan Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 42. Taiwan Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 43. Australia Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 44. Australia Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 45. Australia Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 46. Rest of Asia-Pacific Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 47. Rest of Asia-Pacific Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 48. Rest of Asia-Pacific Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 49. Europe Desmopressin Acetate, by Country USD Million (2017-2022)
  • Table 50. Europe Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 51. Europe Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 52. Europe Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 53. Germany Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 54. Germany Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 55. Germany Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 56. France Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 57. France Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 58. France Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 59. Italy Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 60. Italy Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 61. Italy Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 62. United Kingdom Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 63. United Kingdom Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 64. United Kingdom Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 65. Netherlands Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 66. Netherlands Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 67. Netherlands Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 68. Rest of Europe Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 69. Rest of Europe Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 70. Rest of Europe Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 71. MEA Desmopressin Acetate, by Country USD Million (2017-2022)
  • Table 72. MEA Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 73. MEA Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 74. MEA Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 75. Middle East Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 76. Middle East Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 77. Middle East Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 78. Africa Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 79. Africa Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 80. Africa Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 81. North America Desmopressin Acetate, by Country USD Million (2017-2022)
  • Table 82. North America Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 83. North America Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 84. North America Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 85. United States Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 86. United States Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 87. United States Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 88. Canada Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 89. Canada Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 90. Canada Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 91. Mexico Desmopressin Acetate, by Type USD Million (2017-2022)
  • Table 92. Mexico Desmopressin Acetate, by Route of Administration USD Million (2017-2022)
  • Table 93. Mexico Desmopressin Acetate, by Distribution Channel USD Million (2017-2022)
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Desmopressin Acetate: by Type(USD Million)
  • Table 105. Desmopressin Acetate Diabetes Insipidus , by Region USD Million (2023-2028)
  • Table 106. Desmopressin Acetate Nighttime Bedwetting , by Region USD Million (2023-2028)
  • Table 107. Desmopressin Acetate: by Route of Administration(USD Million)
  • Table 108. Desmopressin Acetate Oral , by Region USD Million (2023-2028)
  • Table 109. Desmopressin Acetate Intravenous (IV) , by Region USD Million (2023-2028)
  • Table 110. Desmopressin Acetate: by Distribution Channel(USD Million)
  • Table 111. Desmopressin Acetate Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 112. Desmopressin Acetate Online Pharmacies , by Region USD Million (2023-2028)
  • Table 113. Desmopressin Acetate Hospitals Pharmacies , by Region USD Million (2023-2028)
  • Table 114. South America Desmopressin Acetate, by Country USD Million (2023-2028)
  • Table 115. South America Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 116. South America Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 117. South America Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 118. Brazil Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 119. Brazil Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 120. Brazil Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 121. Argentina Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 122. Argentina Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 123. Argentina Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 124. Rest of South America Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 125. Rest of South America Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 126. Rest of South America Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 127. Asia Pacific Desmopressin Acetate, by Country USD Million (2023-2028)
  • Table 128. Asia Pacific Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 129. Asia Pacific Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 130. Asia Pacific Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 131. China Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 132. China Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 133. China Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 134. Japan Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 135. Japan Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 136. Japan Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 137. India Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 138. India Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 139. India Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 140. South Korea Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 141. South Korea Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 142. South Korea Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 143. Taiwan Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 144. Taiwan Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 145. Taiwan Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 146. Australia Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 147. Australia Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 148. Australia Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 149. Rest of Asia-Pacific Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 150. Rest of Asia-Pacific Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 151. Rest of Asia-Pacific Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 152. Europe Desmopressin Acetate, by Country USD Million (2023-2028)
  • Table 153. Europe Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 154. Europe Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 155. Europe Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 156. Germany Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 157. Germany Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 158. Germany Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 159. France Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 160. France Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 161. France Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 162. Italy Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 163. Italy Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 164. Italy Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 165. United Kingdom Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 166. United Kingdom Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 167. United Kingdom Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 168. Netherlands Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 169. Netherlands Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 170. Netherlands Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 171. Rest of Europe Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 172. Rest of Europe Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 173. Rest of Europe Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 174. MEA Desmopressin Acetate, by Country USD Million (2023-2028)
  • Table 175. MEA Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 176. MEA Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 177. MEA Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 178. Middle East Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 179. Middle East Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 180. Middle East Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 181. Africa Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 182. Africa Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 183. Africa Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 184. North America Desmopressin Acetate, by Country USD Million (2023-2028)
  • Table 185. North America Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 186. North America Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 187. North America Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 188. United States Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 189. United States Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 190. United States Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 191. Canada Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 192. Canada Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 193. Canada Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 194. Mexico Desmopressin Acetate, by Type USD Million (2023-2028)
  • Table 195. Mexico Desmopressin Acetate, by Route of Administration USD Million (2023-2028)
  • Table 196. Mexico Desmopressin Acetate, by Distribution Channel USD Million (2023-2028)
  • Table 197. Research Programs/Design for This Report
  • Table 198. Key Data Information from Secondary Sources
  • Table 199. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Desmopressin Acetate: by Type USD Million (2017-2022)
  • Figure 5. Global Desmopressin Acetate: by Route of Administration USD Million (2017-2022)
  • Figure 6. Global Desmopressin Acetate: by Distribution Channel USD Million (2017-2022)
  • Figure 7. South America Desmopressin Acetate Share (%), by Country
  • Figure 8. Asia Pacific Desmopressin Acetate Share (%), by Country
  • Figure 9. Europe Desmopressin Acetate Share (%), by Country
  • Figure 10. MEA Desmopressin Acetate Share (%), by Country
  • Figure 11. North America Desmopressin Acetate Share (%), by Country
  • Figure 12. Global Desmopressin Acetate share by Players 2022 (%)
  • Figure 13. Global Desmopressin Acetate share by Players (Top 3) 2022(%)
  • Figure 14. Global Desmopressin Acetate share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Ferring Pharmaceuticals Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Ferring Pharmaceuticals Inc. (United States) Revenue: by Geography 2022
  • Figure 18. American Regent Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 19. American Regent Inc.(United States) Revenue: by Geography 2022
  • Figure 20. Sun Pharmaceutical Industries Ltd(India) Revenue, Net Income and Gross profit
  • Figure 21. Sun Pharmaceutical Industries Ltd(India) Revenue: by Geography 2022
  • Figure 22. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 23. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2022
  • Figure 24. Glenmark Pharmaceuticals(India) Revenue, Net Income and Gross profit
  • Figure 25. Glenmark Pharmaceuticals(India) Revenue: by Geography 2022
  • Figure 26. Mylan N.V.(United States) Revenue, Net Income and Gross profit
  • Figure 27. Mylan N.V.(United States) Revenue: by Geography 2022
  • Figure 28. Pfizer(United States) Revenue, Net Income and Gross profit
  • Figure 29. Pfizer(United States) Revenue: by Geography 2022
  • Figure 30. Dr. Reddy's Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 31. Dr. Reddy's Laboratories (India) Revenue: by Geography 2022
  • Figure 32. BluePoint Laboratories (Ireland) Revenue, Net Income and Gross profit
  • Figure 33. BluePoint Laboratories (Ireland) Revenue: by Geography 2022
  • Figure 34. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 35. Sanofi (France) Revenue: by Geography 2022
  • Figure 36. Global Desmopressin Acetate: by Type USD Million (2023-2028)
  • Figure 37. Global Desmopressin Acetate: by Route of Administration USD Million (2023-2028)
  • Figure 38. Global Desmopressin Acetate: by Distribution Channel USD Million (2023-2028)
  • Figure 39. South America Desmopressin Acetate Share (%), by Country
  • Figure 40. Asia Pacific Desmopressin Acetate Share (%), by Country
  • Figure 41. Europe Desmopressin Acetate Share (%), by Country
  • Figure 42. MEA Desmopressin Acetate Share (%), by Country
  • Figure 43. North America Desmopressin Acetate Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Ferring Pharmaceuticals Inc. (United States)
  • American Regent Inc.(United States)
  • Sun Pharmaceutical Industries Ltd(India)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Glenmark Pharmaceuticals(India)
  • Mylan N.V.(United States)
  • Pfizer(United States)
  • Dr. Reddy's Laboratories (India)
  • BluePoint Laboratories (Ireland)
  • Sanofi (France)
Select User Access Type

Key Highlights of Report


Dec 2023 205 Pages 90 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Desmopressin Acetate Market Quantitative research analysis
Global Desmopressin Acetate Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Ferring Pharmaceuticals Inc. (United States), American Regent Inc.(United States), Sun Pharmaceutical Industries Ltd(India), Teva Pharmaceutical Industries Ltd. (Israel), Glenmark Pharmaceuticals(India), Mylan N.V.(United States), Pfizer(United States), Dr. Reddy's Laboratories (India), BluePoint Laboratories (Ireland) and Sanofi (France) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Efforts to increase awareness by various childcare non-profit organizations" is seen as one of major influencing trends for Desmopressin Acetate Market during projected period 2022-2028.
The Desmopressin Acetate market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Desmopressin Acetate Market Report?

Have a Query? Click Here

Other Related Reports

Ewing Sarcoma Drugs Comprehensive Study by Type (Vincristine, Cyclophosphamide, Doxorubicin, Etoposide, Ifosfamide, Dactinomycin), Application (Hospitals, Homecare, Specialty Clinics, Others), Diagno...
$ 3750
Pharmaceutical Packaging Materials Comprehensive Study by Type (Glass, Plastic, Rubber, Paper or Cardboard, Metal (Tin, Aluminum, Lead), Others), Application (Pharmaceutical Firms, Biotechnological F...
$ 3650
Biodegradable Pharmaceutical Packaging Comprehensive Study by Type (Plastic (Starch-Based Plastics, Cellulose-Based Plastics, Polylactic Acid (PLA), Polyhydroxyalkanoates (PHA), Other), Paper), Appli...
$ 3650
Pregnant Vitamin and Supplements Comprehensive Study by Type (Vitamins, Minerals (Calcium, Iron, and others), Essential Fatty Acids, Others), Application (Pharmacies, Healthcare centers, Hospitals an...
$ 3650
Digital Medicines Comprehensive Study by Type (Mobile Health, EMR/EHR, Telehealth, Wireless Health), Application (Diabetes, Mental Health, Heart Disease, Smoking, Drug Non-adherence, Obesity, COPD, A...
$ 3800
Sevoflurane Source Comprehensive Study by Type (Human Series, Animal Series), Application (Hospitals, Other Medical Institutions) Players and Region - Global Market Outlook to 2028
$ 3500